Azadeh et al. meta-analysis of IL-17 inhibitors in ankylosing spondylitis identified significantly increased mucosal/opportunistic infection risks (RD = 0.09, p = 0.02), recommending adjunct antifungal prophylaxis (100). Here, IL17A is linked to Opportunistic infection.